This supplement is based on a meeting of leading experts in rheumatology to discuss treatment options for rheumatoid arthritis. The goal of this meeting was to create a step-care algorithm for treatment. The presentations herein address advances in combination therapy that have resulted in a significant reduction in disease-related disability, measurable improvement in quality of life, and a substantial decrease in economic losses.
Pharmaceutical Agents for the Treatment of Rheumatoid Arthritis
Combination DMARD Therapy for Rheumatoid Arthritis
Economic and Quality-of-Life Impact of Rheumatoid Arthritis